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Abstract
Background: After two-years of follow-up of 263 apparently healthy 18- to 30-year-old men in communities
affected by Mesoamerican nephropathy (MeN), we identified three distinct case groups: a subgroup with (i)
established renal dysfunction (case-group 1); individuals with (ii) a rapid decline in kidney function (case-group 2);
and individuals with (iii) stable kidney function (non-cases). This paper investigates whether local tests are
potentially useful for the timely identification of these case groups.
Methods: Creatinine levels were measured in local laboratories every six months for two years. Aliquots were sent
to a centralized laboratory for measurements of cystatin C and creatinine levels. We investigated agreement
between the locally and centrally measured creatinine-based Chronic Kidney disease Epidemiology Collaboration
(CKD-EPI) equation for estimating the Glomerular Filtration Rate (eGFR). A logistic regression analysis was used to
assess predictive factors for case groups 1 and 2 compared to non-cases. Predictive variables were locally measured
eGFR, and urinary neutrophil gelatinase-associated lipocalin (uNGAL) levels. The discrimination performance of the
model was assessed using the area under the receiver operating characteristic curve (AUC).
Results: Considerable variation in local eGFR measurements was observed. The prediction model for case-group 1
included baseline kidney function and with or without uNGAL (AUC = 0.98, 95% confidence interval (CI), 0.91–1.00).
The prediction model for case-group 2 also required eGFRScr at six and twelve months after baseline, with or
without uNGAL levels (AUC = 0.88; 95% CI 0.80–0.99).
Conclusions: Established renal dysfunction was detected at a single time point using local measurements and
uNGAL. For the detection of a rapid decline in kidney function over time, at least 2 more measurements at six and
twelve months are needed.
Keywords: Mesoamerican nephropathy, Chronic kidney disease of unknown aetiology, Prediction, Kidney function
status, Serum creatinine, uNGAL, ROC, Nicaragua
Background
Mesoamerican nephropathy (MeN) is a major public
health and economic problem affecting rural and agricul-
tural communities in Mesoamerica. Over the last decade,
MeN, also known as chronic kidney disease of unknown
aetiology (CKDu), has caused the deaths of thousands of
vulnerable young male agricultural workers, particularly
sugarcane workers and other workers (agricultural and
non-agricultural) who work in extremely hot conditions
along the Pacific coast of Mesoamerica [1–5]. MeN has
devastating consequences for patients, family members,
communities and the country, with patients who are diag-
nosed with the disease progressing to end stage renal dis-
ease as young and middle-aged adults. Renal replacement
therapy options are expensive and limited in Mesoamerica,
resulting in the high mortality of patients with MeN [6, 7].
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MeN disease has some unique characteristics, includ-
ing the absence of traditional risk factors (hypertension
and diabetes) [1, 8, 9]. A recent systematic review identi-
fied that the male gender, living in lowlands, a family his-
tory of CKD and a high water-intake are associated with
CKDu [10]. Some studies have reported elevated urinary
neutrophil gelatinase-associated lipocalin (uNGAL) and
N-acetyl-β-D-glucosaminidase (NAG) levels in sugarcane
workers [11, 12]. Therefore, one current hypothesis is that
MeN is caused by repetitive acute kidney injury due to
multiple risk factors, such as working conditions and heat
[1, 8].
We have recently conducted a community-based co-
hort study in the affected region. We used established
biomarkers of kidney function (serum cystatin C (Scys)
and serum creatinine (Scr) levels) that were measured in
stored samples from baseline and 6-month follow-up
visits in a central laboratory at the end of the study (five
measures in total) to determine the decline in kidney
function after 2 years of follow-up. [13, 14] Although we
attempted to recruit people without established kidney dis-
ease at baseline, 25 people (10.5% of the cohort) who were
apparently healthy but in fact had established kidney dys-
function at baseline were included. An additional
sub-group of males (10.5% of the total cohort) exhibited an
extremely rapid decline in kidney function of 18.2mL/min/
1.73m2/year from normal levels [14]. The observed dra-
matic loss of renal function among a sizeable sub-group of
an apparently healthy young population is a concern.
The local industries in Nicaragua have established baseline
screening programmes for kidney dysfunction using a single
local creatinine test [15]. Despite the use of this local screen-
ing programme, a sub-group of people with established kid-
ney disease was recruited in our study; therefore, a question
arises of whether other information is needed in addition to
a single serum creatinine measurement to detect MeN. In
addition, the identification of the subgroup that will experi-
ence a rapid decline in kidney function will be beneficial to
provide advice (e.g., avoidance of known nephrotoxins, such
as non-steroidal anti-inflammatory drugs) and potentially to
implement interventions (e.g., improve work conditions,
clean water etc., if these interventions are proven to be ef-
fective) to prevent or delay future kidney function loss. Serial
measurements of serum creatinine levels over more than 2
years are not the usual practice in Nicaragua. Therefore, the
purpose of this analysis is to determine if repeated local cre-
atinine tests combined with urinary measurements of
uNGAL levels can identify the subgroup of individuals at
risk of a future rapid decline in kidney function.
Methods
Study population
These analyses are based on our existing community-based
follow-up study of a decline in kidney function among
affected communities in Nicaragua. The rationale and study
design have been published elsewhere [13]. Briefly, we re-
cruited 350 apparently healthy young adults aged 18–30
years without a known diagnosis of CKDu and traditional
risk factors, and followed them for two years. All eligible
healthy males and a sample of females from 9 communities
in northwest Nicaragua were enrolled in our study. Bio-
logical samples, anthropometric measurements and ques-
tionnaire data were collected at baseline and then at
six-month intervals. The outcome was the kidney function
status, and we classified the participants into three categor-
ies: (i) established renal dysfunction; (ii) a rapid decline in
kidney function; and (iii) stable kidney function [14].
Clinical measurements
Gold standard
All samples were analysed in a single batch to reduce
time-dependent measurement errors in the assays after
two years of follow-up. At the end of the follow-up
period, stored (− 80 °C) serum aliquots from all study
visits were transferred to the Clinical Trial Service Unit
at Oxford University. Scr levels were quantified using a
Beckman AU680 Chemistry Analyser (Jaffe compensated
method) and calibrated against the IDMS-traceable cre-
atinine standard. Scys levels were measured using Sie-
mens BN ProSpec (nephelometry) [14]. The CKD-EPI
equation for serum creatinine and cystatin c levels was
used to estimate the estimated glomerular filtration rate,
or eGFR (eGFRScr-Scys) [16].
Routine local measurements
Serum creatinine (Scr) levels were also measured locally
(in the Biochemistry Department at the National Autono-
mous University of Nicaragua-Leon) using a ChemWell®
2910 (Awareness Technology, EEUU) auto analyser (Jaffe
compensated method) [17, 18]. Local Scr values were
multiplied by 0.95, as they were not calibrated to an
IDMS-traceable creatinine standard [19]. Kidney function
was calculated using the estimated glomerular filtration
rate according to the CKD-EPI formula by determining
Scr levels [16] at each study visit.
Urine markers
Creatinine and albumin levels in baseline urine samples,
which were previously frozen and stored at − 80 °C for
2.5 years, were measured using the Jaffe and bromocre-
sol green reactions (Sigma-Aldrich, MAK124), respect-
ively. Samples were read at a specific wavelength using
the Biochrom EZ Read 400 Microplate Reader. Urinary
neutrophil gelatinase-associated lipocalin (uNGAL)
levels were measured in a subsample. Samples from
fifty-five randomly selected participants with stable kid-
ney function and samples from all participants in the
other two subgroups (rapid decline in kidney function
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and patients with established renal dysfunction; both of
which are defined below) were analysed. uNGAL levels
were measured using enzyme-linked immunoassay
(ELH-Lipocalin2, RayBiotech), according to the manu-
facturer’s instructions. Albumin and uNGAL levels are
reported as ratios to urinary creatinine levels measured
using the Jaffe method (Sigma-Aldrich, C4255) [14].
Definitions of outcome categories
A growth mixture model (GMM) was used to identify
three sub-groups of kidney function in males using the
gold standard eGFR after 2 years, as previously described
[14]. A group with established renal dysfunction at base-
line (mean eGFRScr-Scys: 58 mL/min/1.73 m
2) was investi-
gated, which for the purpose of this paper, is defined as
case-group 1. Then, a group with normal baseline kidney
function (mean eGFR: 112mL/min/1.73 m2) showed a
rapid decline in eGFRScr-Scys of − 18.2mL/min/1.73m
2/year
and were designated case-group 2, i.e., rapid decliners. The
remaining study participants were ‘non-cases’ with stable kid-
ney function, i.e., men with persistently stable kidney func-
tion (mean baseline eGFR: 116mL/min/1.73m2) and an
annual decline in eGFRScr-Scys of only − 0.6mL/min/1.73m
2/
year over two years. The analyses compared each of the two
case groups with the non-cases. Given the small number of
affected females exhibiting a rapid decline in kidney function
(3 cases), formal analyses were restricted to males.
Variables
Each participant completed a baseline questionnaire by
face-to-face interview that included demographic data,
current and previous occupations, lifestyle factors, medi-
cations, liquid intake, and dehydration symptoms [13, 14].
The season was defined as summer and winter. Work per-
formed was classified as outdoor and indoor work. For
this analysis, we used the eGFR and uNGAL levels, but in
a sensitivity analysis the baseline questionnaire data (age,
season, work performed, urinary albumin-creatinine ratio
(UACR)) were included as part of the full model. UACR
was categorized as a ratio ≥ 30mg/g or < 30mg/g [20].
Statistical analysis
Descriptive analyses of continuous variables (age, serum
creatinine, eGFRScr, eGFRScr-Scys, and uNGAL) stratified
by case/non-case status were conducted, and are reported
as the means (SD) or medians and interquartile ranges
(IQRs). Categorical variables (season, work performed and
UACR) are reported as frequencies and percentages.
For the identification of cases of MeN in the local setting,
local measurements are required; therefore, the current ana-
lysis is based on the routine creatinine measurements per-
formed after each visit. The agreement between the estimated
GFR based on the Scr Jaffe assay conducted at the laboratory
in Nicaragua and the eGFRScr from Oxford (gold-standard
measure) was evaluated at three time points (baseline, 6 and
12months) using a Bland-Altman plot.
For case-group 1, we first assessed whether the routine
eGFR data derived from local creatinine measurements
identified people with established kidney damage. Logistic
regression models were also performed to compare
case-group 1 with non-cases. Model 1 included eGFRScr at
baseline; Model 2 included the Model 1 covariate plus
uNGAL levels. Along with variables included in Models 1
and 2, subsequent models for non-cases and case-group 2
also included the 6- and/or 12-month eGFR with or with-
out uNGAL levels.
For all models, receiver operating characteristic (ROC)
curves were generated to calculate the area under the
ROC curve (AUC). An AUC greater than 0.80 was consid-
ered a suitable discrimination performance for the model.
In order to check that the results are not confounded,
we repeated the analysis using only the continuous
eGFR, and uNGAL measurements with further adjust-
ments for other variables such us age, season, work per-
formed, and urinary albumin-creatinine ratio
(UACR) (Table 1).
All statistical analyses were performed using Stata soft-
ware, version 14 (Stata Corp.).
Results
Agreement between clinical measurements – Routine
eGFRScr-Nicaragua compared to the gold-standard eGFRScr-Oxford
In daily clinical practice, eGFRScr measurements are used,
and we compared these values to gold-standard eGFR-
Scr-Oxford. The mean difference in baseline kidney function
based on serum creatinine levels measured in Nicaragua
compared to serum creatinine levels measured in Oxford
was − 10.47mL/min/1.73m2 (95% CI -11.90 to − 9.03),
suggesting that Nicaraguan kidney function was overesti-
mated by local measurements. The limits of agreement
ranged from − 37.24 to 16.30mL/min/1.73m2 with a vari-
ability of 3.7%, suggesting that local measurements varied.
No evidence of the measurement error in eGFRScr was
observed, with a poor correlation between the difference
and the sums (r = − 0.06; P = 0.213) (Additional file 1:
Figure S1A). The mean difference in eGFRScr-Nicaragua after
6months was − 8.39mL/min/1.73m2 (95% CI -9.91 to −
6.88), with a range of 22.07 to 152.35mL/min/1.73m2.
The limits of agreement were − 35.09 to 18.30mL/min/
1.73m2 and the variability was 5.4% (Additional file 1:
Figure S1B). Finally, the mean difference in eGFRScr-Nicaragua
at the third study visit was + 3.44mL/min/1.73m2 (95% CI
1.76 to 5.11), with a range of 15.54 to 146.33mL/min/
1.73m2. The limits of agreement were − 26.90 to 33.17
mL/min/1.73m2 and the variability was 7.2%. A weak
correlation between the difference and the sums was
observed for both lab results (r = − 0.11; P = 0.042)
(Additional file 1: Figure S1C).
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General characteristics stratified by kidney function
trajectories
The mean age at baseline for the entire men population
was 23.7 ± 3.8 years. The majority of males (74%) re-
ported that they worked outdoors. Table 2 shows the
routine local clinical kidney measurements at baseline
stratified according to the observed renal outcome
groups after 2 years of follow-up. At baseline, no differ-
ences were observed between controls and case-group 2.
However, a subgroup of males had a high serum creatin-
ine level and low eGFRScr at baseline, and were unaware
of this condition at recruitment into the study (case--
group 1). Case-group 1 displayed a high urinary uNGAL
level at baseline. However, the percentages of males dis-
playing a UACR ≥30mg/g were 4.7% among participants
with stable kidney function and 16% among participants
with established renal dysfunction (case-group 1).
Model for predicting established renal dysfunction
The prediction score comparing stable kidney function
(non-cases) and established renal dysfunction (case-group
1) without uNGAL levels by using a single eGFRScr meas-
urement was excellent (P < 0.001), showing an AUC of
0.97 (95% CI 0.93–1.00) (Additional file 1: Table S1;
Model 1). The AUC for Model 2, where a single eGFRScr
measurement and uNGAL levels did not improve the
prediction compared with established predictors, was 0.98
(95% CI 0.95–1.00). The c statistic was the same for both
models. (Fig. 1 and Additional file 1: Table S1).
Model for predicting a rapid decline in kidney function
The AUC just for the estimated glomerular filtration rate
at baseline showed a poor discrimination to identify
populations at risk of a rapid decline in kidney function
(case-group 2). As shown in Fig. 2a, the discrimination
power of the model at baseline was poor, with an AUC
of 0.51 (95% CI 0.34–0.69), and when uNGAL was
added to the logistic regression model, the AUC was
0.75 (95% CI 0.57–0.92). The c statistic for Model 4 with
uNGAL levels was 0.24 higher, indicating a significant
improvement compared with Model 3 that did not in-
clude uNGAL levels.
Figure 2b shows the results of the model without
uNGAL levels, but with an additional measurement of
eGFRScr at 6 months (Model 5). The discrimination power
of the model was somewhat improved (compared to
Model 3), with an AUC of 0.71 (95% CI 0.56–0.85). For
the same variables with the addition of uNGAL levels
(Model 6), the AUC was 0.73 (95% CI 0.58–0.88). The c
statistic for model 6 (with uNGAL levels) was 0.02.
Figure 2c shows the results of the models including an
eGFRScr recorded 12 months after the baseline measure
Table 1 Variables outlined in each of the models stratified by case-groups
Variables Case-group 1 Case-group 2
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 Model 9 Model 10
Age X X X X X X X X X X
Season X X X X X X X X X X
Occupation (outdoor work) X X X X X X X X X X
UACR X X X X X X X X X X
UNGAL X X X X X
eGFRScr at baseline X X X X X X X X X X
eGFRScr at 6 months X X X X
eGFRScr at 12 months X X X X
Table 2 Baseline characteristics of apparently healthy young men in northwest Nicaragua stratified by trajectories of a future decline
in kidney function using gold standard measurements (CKDEPI Creat/Cyst eGFR) (n = 263)
Trajectories of the decline in
kidney function
N Age at baseline
(Mean; SD)
Serum creatinine
level at baseline‡
(Median; IQR)
eGFRScr at
baseline‡
(Median; IQR)
eGFRScr-Scys at
baseline†
(Median; IQR)
Urinary NGAL
level at baseline◊
(Median; IQR)
UACR ≥30
mg/dL at
baseline◊ (n; %)
Outdoor
work at
baseline (n; %)
Stable kidney function
(−0.6 mL/min/1.73 m2/year)
213 23.6 ± 3.89 0.76 (0.57–0.76) 131 (124–140) 118 (108–125) 5.04 (4.7–5.4) 10 (4.7) 151 (70.9)
Rapid decline in kidney
function (− 18.2 mL/min/1.73
m2/year)
25 23.3 ± 3.65 0.66 (0.47–0.76) 132 (123–152) 117 (103–124) 5.20 (5.0–5.5) 0 (0) 24 (96.0)
Renal dysfunction
(− 3.8 mL/min/1.73 m2/year)
25 25.4 ± 2.97 1.23 (1.14–1.52) 80 (62–91) 56 (49–68) 5.7 (5.5–5.7) 4 (16.0) 19 (76.0)
Total 263 23.7 ± 3.82 0.76 (0.66–0.85) 129 (121–139) 116 (102–125) 5.20 (4.9–5.7) 14 (5.3) 194 (73.8)
‡Routine local test measurement. †Gold-standard outcome measured in Oxford 2 years later. ◊Urinary biomarkers of kidney injury
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(excluding the 6-month measurement; Model 7), with an
AUC of 0.80 (95% CI 0.70–0.91). The addition of
uNGAL levels (Model 8) to this model yielded an AUC
of 0.81 (95% CI 0.72–0.91). The c statistic was almost in-
distinguishable between model 7 and model 8, suggest-
ing that uNGAL levels do not additional predictive value
to model 7.
The best prediction of a future rapid decline in kidney
function (Fig. 2d) was achieved using 3 eGFRScr mea-
surements: baseline, 6 months and 12months (Model 9).
This model yielded an AUC of 0.88 (95% CI 0.79–0.98)
and an AUC of 0.89 (95% CI 0.80–0.99) when urinary
uNGAL levels were incorporated into the model (Model
10). Again, the c statistics were similar between Models
9 and 10 (Fig. 2 and Additional file 1: Table S2).
Results of the sensitivity analysis using eGFR, uNGAL
measurements plus baseline questionnaire data (age, season,
work performed, and UACR) were not appreciably changed
when compared to the main analysis (Additional file 1:
Figures S2 and S3 and Additional file 1: Table S3 and S4).
Discussion
Using a gold-standard measurement of decline in kidney
function, we classified the participants into three categor-
ies: (i) established renal dysfunction (case-group 1); (ii) a
rapid decline in kidney function (case-group 2); and (iii)
stable kidney function (non-cases). We then compared
each of the two case-groups with the non-cases. While it
was straightforward to identify individuals with already
established renal dysfunction at baseline using routine la-
boratory data together with uNGAL (AUC: 0.98; 95% CI:
0.95 to 1.00), a follow-up for at least one year with 6
monthly measurements was required to identify most
people who will suffer from a future rapid decline in kid-
ney function from normal participants (AUC: 0.89; 95%
CI: 0.80 to 0.99 and a false positive rate of 0.5). We did
not observe a difference in the ROC values in the final
model with and without uNGAL levels and note that the
confidence intervals nearly overlapped.
Good quality laboratory results are very important for an
accurate diagnosis and clinical decision making [21–24].
The laboratory in Nicaragua is not accredited to ISO stan-
dards; however, as happens in routine clinical care, the ma-
chines are regularly recalibrated. Routine clinical care
procedure do not standardly bank blood samples for several
years to then retrospectively assess decline in kidney func-
tion. We showed that routine clinical care measurements
displayed considerable time-dependent variability. The vari-
ability in the local Scr measurements increased the impreci-
sion between the eGFRScr-Nicaragua and the gold-standard
(eGFRScr-Oxford) of 3.7% at baseline and 7.2% at the third
study visit. However, for the eGFR determinations per-
formed following the baseline visit, measurement error ap-
peared to have decreased as the laboratory obtaining a
better machine recalibration, maintenance and the imple-
mentation of external quality control standards. Based on
these findings, health care providers and researchers must
be aware of the challenges of using local serum creatinine
measurements.
To date, many prediction models have been developed
and validated for determining the progression of kidney
disease to ESRD [25, 26]. Roy et al. developed a prediction
model and showed how a novel biomarker (uNGAL) im-
proves prediction of CKD progression in the CRIC study
[27]. Their model included demographic data plus
uNGAL levels, and the model without uNGAL levels
showed a poor discrimination power (AUC= 0.69),
whereas the model with uNGAL levels exhibited good dis-
crimination (AUC = 0.82). Our model with uNGAL levels
used to distinguish participants with renal dysfunction
(case-group 1) did not add predictive value beyond the
established predictors (AUC= 0.98) compared to the
model without uNGAL levels (AUC = 0.97).
When predicting a future rapid decline in kidney function
(case-group 2), the addition of uNGAL levels to the model
that included a single eGFRScr measurement increased the
AUC from 0.51 to 0.75 (Model 3 vs Model 4). However, in
the models including three eGFR measurements (Model 9
vs Model 10) the two curves were almost indistinguishable
(e.g., AUCs with and without uNGAL levels were 0.88 and
0.89 respectively for models 9 and 10). Thus, no discernible
Fig. 1 ROC curves for the model predicting stable kidney function
versus established renal dysfunction using eGFR and uNGAL. The
95% confidence intervals for the ROC curves (0.5) are displayed
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improvement in prediction was observed when uNGAL
levels were added to a model containing more than one
creatinine measurement recorded over time.
The key implication from our study for future cohort
and/or intervention studies of CKDu is that the minimal
follow-up period is one year, and 6 monthly measurements
are required to distinguish the progressive loss of eGFR
from stable kidney function. Any study with a shorter
follow-up period less likely to detect significant progression
among participants with normal function at baseline.
Our study has methodological strengths. First, this study
is derived from a community-based longitudinal study of
apparently healthy young adults in high-risk areas for
CKDu. Second, the variables that were used to calculate
the prediction score are easy to obtain at any health level
(i.e., primary, secondary and tertiary health levels) and can
be applied by doctors or any health professional.
Our study has some limitations that should be noted.
External validation was not performed because this
community-based cohort study is the first in the region,
and no other comparable cohorts are available. Second,
we were unable to assess the effect of the season in
which eGFR measures are performed because almost all
participants were recruited before the harvest season
[14].
Conclusions
In conclusion, established renal dysfunction was detected
at a single time point using local measurements of eGFR
and uNGAL. However, the detection of a rapid decline in
kidney function over time requires at least 2 measure-
ments, ideally at least twelve months apart. In addition,
local routine clinical measurements of creatinine levels
are affected by time-dependent measurement error.
Fig. 2 ROC curves for the model predicting stable kidney function versus a rapid decline in kidney function using eGFR and uNGAL. The 95%
confidence intervals for ROC curves (0.5) are displayed. The blue label means: Area under the curve without uNGAL. The maroon label means:
Area under the curve with uNGAL
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Additional file
Additional file 1: Figure S1. Bland-Altman plot of eGFR based on
serum creatinine levels measured in Nicaragua and serum creatinine
levels measured in London. Figure S2. ROC curves for the model predict-
ing stable kidney function versus established renal dysfunction. The 95%
confidence intervals for the ROC curves (0.5) are displayed. Figure S3.
ROC curves for the model predicting stable kidney function versus a rapid
decline in kidney function. The 95% confidence intervals for ROC curves
(0.5) are displayed. Table S1. Multivariate adjusted logistic regression ana-
lysis for eGFR and uNGAL with established renal dysfunction at baseline
among apparently healthy young males. Table S2. Multivariate adjusted
logistic regression analysis for eGFR and uNGAL with a rapid decline in
kidney function at baseline among apparently healthy young males.
Table S3. Multivariate adjusted logistic regression analysis of factors asso-
ciated with established renal dysfunction at baseline among apparently
healthy young males. Table S4. Multivariate adjusted logistic regression
analysis for factors associated with a rapid decline in kidney function at
baseline among apparently healthy young males. (PDF 600 kb)
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